First Trust Nasdaq Pharmaceuticals ETF Rating $28.10 -0.24 (-0.85%) (As of 11/4/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy2.63Holdings in FTXH have an aggregate rating of Moderate Buy based on 695 analyst ratings issued in the past year covering 50 companies (99.9% of the portfolio).FTXH Aggregate Price Target$33.2718.38% UpsideHigh Prediction$41.09Average Prediction$33.27Low Prediction$25.82Holdings in FTXH have an aggregate price target of $33.27 and a range of $25.82 to $41.09 covering 50 companies (99.9% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.00%BMYBristol-Myers Squibb$55.45+2.1%4.5192 of 5 stars1.93$53.00 -4.4%14Earnings ReportAnalyst ForecastAnalyst Revision7.45%JNJJohnson & Johnson$158.24-1.2%4.9744 of 5 stars2.54$175.93 11.2%137.45%PFEPfizer$27.76-1.2%4.9858 of 5 stars2.60$33.58 21.0%15Earnings ReportAnalyst Revision7.29%ABBVAbbVie$200.47-1.5%4.8436 of 5 stars2.84$201.00 0.3%20Earnings ReportDividend IncreaseAnalyst UpgradeAnalyst Revision6.75%MRKMerck & Co., Inc.$101.870.0%4.9986 of 5 stars2.88$129.93 27.5%17Earnings ReportAnalyst Forecast4.24%GILDGilead Sciences$89.84+0.4%4.9182 of 5 stars2.65$86.85 -3.3%23Upcoming Earnings3.76%CAHCardinal Health$111.90-3.6%4.8408 of 5 stars2.50$120.18 7.4%13Earnings ReportAnalyst DowngradeAnalyst RevisionNews CoverageHigh Trading Volume3.73%ZTSZoetis$175.18-3.7%4.9836 of 5 stars3.10$221.44 26.4%10News CoverageGap Down3.59%VTRSViatris$11.45-1.5%2.5281 of 5 stars2.50$14.00 22.3%2Upcoming Earnings3.57%AMGNAmgen$316.91-0.7%4.5064 of 5 stars2.50$333.50 5.2%24Earnings ReportAnalyst UpgradeAnalyst Revision3.51%UTHRUnited Therapeutics$376.80+0.7%4.6373 of 5 stars2.73$370.86 -1.6%15Earnings ReportInsider Selling3.50%LLYEli Lilly and Company$806.14-1.6%4.9808 of 5 stars2.84$1,008.41 25.1%19Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision3.39%BIIBBiogen$173.52-0.2%4.8315 of 5 stars2.62$261.58 50.8%26Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading Volume2.99%JAZZJazz Pharmaceuticals$109.41-0.9%4.7796 of 5 stars2.79$173.43 58.5%14Upcoming Earnings2.96%REGNRegeneron Pharmaceuticals$828.84-1.7%4.8372 of 5 stars2.71$1,097.25 32.4%21Analyst Forecast2.72%OGNOrganon & Co.$16.92-6.4%4.8919 of 5 stars2.50$21.33 26.1%4Earnings ReportDividend AnnouncementHigh Trading Volume2.28%CRLCharles River Laboratories International$182.48+0.8%4.6124 of 5 stars1.93$209.00 14.5%15Upcoming Earnings1.75%MEDPMedpace$317.96-0.5%4.8506 of 5 stars2.45$380.00 19.5%111.61%ELANElanco Animal Health$12.56-0.3%4.1593 of 5 stars2.43$17.00 35.4%7Upcoming Earnings1.30%NBIXNeurocrine Biosciences$120.53-1.4%4.9154 of 5 stars2.83$163.91 36.0%24Analyst ForecastAnalyst Revision1.08%HALOHalozyme Therapeutics$58.47+2.3%4.7098 of 5 stars2.60$61.00 4.3%10Analyst Forecast1.00%ALKSAlkermes$26.59+0.5%4.9111 of 5 stars2.50$34.90 31.3%100.90%PRGOPerrigo$25.41-2.6%4.8692 of 5 stars2.75$37.00 45.6%4Upcoming EarningsDividend Announcement0.89%EXELExelixis$34.29+0.5%4.6445 of 5 stars2.65$31.44 -8.3%20Earnings Report0.86%PBHPrestige Consumer Healthcare$73.79-0.4%4.6487 of 5 stars2.60$94.20 27.7%5Upcoming EarningsPositive News0.80%PTGXProtagonist Therapeutics$46.763.6977 of 5 stars3.17$52.83 13.0%7Upcoming EarningsAnalyst Forecast0.73%ALNYAlnylam Pharmaceuticals$269.95-1.4%3.806 of 5 stars2.75$294.50 9.1%24Earnings ReportAnalyst Forecast0.70%CORTCorcept Therapeutics$50.06+5.1%4.9083 of 5 stars3.00$65.25 30.3%5Earnings ReportAnalyst RevisionNews Coverage0.66%ACLXArcellx$86.44+0.3%1.4602 of 5 stars3.08$89.75 3.8%13Upcoming Earnings0.60%EXASExact Sciences$71.13+1.9%4.2285 of 5 stars2.94$80.64 13.4%160.60%VKTXViking Therapeutics$63.14-13.4%4.2048 of 5 stars3.09$109.80 73.9%11Analyst ForecastNews CoverageGap UpHigh Trading Volume0.54%ITCIIntra-Cellular Therapies$86.17-0.4%4.5862 of 5 stars2.85$96.62 12.1%13Earnings ReportAnalyst ForecastAnalyst Revision0.54%RNAAvidity Biosciences$44.82+7.0%2.0075 of 5 stars3.00$63.22 41.1%90.53%KYMRKymera Therapeutics$47.07+1.3%0.9387 of 5 stars2.80$50.93 8.2%15Earnings ReportAnalyst ForecastAnalyst Revision0.52%TGTXTG Therapeutics$24.36-9.4%4.7875 of 5 stars2.83$36.33 49.2%6News CoverageGap DownHigh Trading Volume0.52%INCYIncyte$75.75-0.5%4.0866 of 5 stars2.38$76.74 1.3%21Earnings Report0.51%ROIVRoivant Sciences$11.53-1.3%3.1081 of 5 stars2.90$17.39 50.8%10Upcoming Earnings0.51%SRPTSarepta Therapeutics$123.07-0.2%4.9474 of 5 stars2.95$182.95 48.7%21Upcoming EarningsPositive News0.50%AMRXAmneal Pharmaceuticals$8.41-0.9%2.9726 of 5 stars2.80$9.40 11.8%5Upcoming Earnings0.50%VRTXVertex Pharmaceuticals$472.80+0.4%3.3118 of 5 stars2.48$492.50 4.2%290.49%INSMInsmed$68.09-0.3%3.8444 of 5 stars3.00$83.07 22.0%16Earnings Report0.49%TWSTTwist Bioscience$42.05+1.2%2.4687 of 5 stars2.67$51.22 21.8%90.48%ADMAADMA Biologics$19.11-1.3%2.5836 of 5 stars3.25$15.50 -18.9%4Upcoming Earnings0.47%KRYSKrystal Biotech$170.85-3.1%4.6808 of 5 stars3.00$196.75 15.2%9News CoverageGap DownHigh Trading Volume0.46%ACADACADIA Pharmaceuticals$14.62-1.3%4.5106 of 5 stars2.65$25.56 74.8%17Upcoming Earnings0.46%BPMCBlueprint Medicines$91.88+1.3%2.1871 of 5 stars2.70$120.39 31.0%20Earnings ReportAnalyst Revision0.45%BMRNBioMarin Pharmaceutical$66.01-0.9%4.968 of 5 stars2.67$94.16 42.6%21Earnings ReportAnalyst Revision0.44%VCELVericel$44.37+0.9%2.6411 of 5 stars3.00$57.71 30.1%7Upcoming EarningsPositive News0.43%IONSIonis Pharmaceuticals$38.44-0.8%4.2378 of 5 stars2.68$61.00 58.7%19Upcoming EarningsAnalyst Upgrade0.40%MYGNMyriad Genetics$17.83-0.9%4.574 of 5 stars2.42$28.91 62.1%12Upcoming EarningsNews CoverageGap DownHigh Trading Volume This page (NASDAQ:FTXH) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts